Myelofibrosis treatments from clinical trials

Myelofibrosis is a rare form of bone marrow cancer that effects the body’s production of blood cells. There are only 1.5 cases per 100,000 people in the United States. Myelofibrosis belongs to a larger family of blood diseases known as Myeloproliferative Disorders. The only known cure available for patients is an allogenic stem cell transplantation, which transfers healthy stem cells from a donor to the patient after they receive chemotherapy or radiation. However, not all patients are eligible for this treatment.

Myelofibrosis clinical trials are a great alternative for those seeking new treatment options. These trials help alleviate symptoms and can improve treatment response. However, there are thousands of trials available and identifying the right one for you can be time-consuming. Using an artificial-intelligence based clinical trial matching tool is helpful by using your medical records to find personalized matches for you to enroll in. Not only will tools like this find trials based on your individual cancer case, but also looks for trials located near you.

Hibya Haber Ajansı

Bir cevap yazın

E-posta hesabınız yayımlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir